{"prompt": "['NRG ONCOLOGY', 'NRG-GU003', '(ClinicalTrials.gov NCT #: 03274687)', 'A RANDOMIZED PHASE III TRIAL OF HYPOFRACTIONATED POST-', 'PROSTATECTOMY RADIATION THERAPY (HYPORT) VERSUS CONVENTIONAL', 'POST-PROSTATECTOMY RADIATION THERAPY (COPORT)', 'Amendment 1: April 26, 2019']['NRG ONCOLOGY', 'NRG-GU003', '(ClinicalTrials.gov NCT # 03274687)(26-APR-2019)', 'A RANDOMIZED PHASE III TRIAL OF HYPOFRACTIONATED POST-', 'PROSTATECTOMY RADIATION THERAPY (HYPORT) VERSUS CONVENTIONAL', 'POST-PROSTATECTOMY RADIATION THERAPY (COPORT)', 'This trial is part of the National Clinical Trials Network (NCTN) program, which is sponsored', 'by the National Cancer Institute (NCI). The trial will be led by NRG Oncology with the', 'participation of the network of NCTN organizations: the Alliance for Clinical Trials in', 'Oncology; ECOG-ACRIN Medical Group; and SWOG.', 'Coordinating Center:', 'NRG Oncology', 'Four Penn Center; 1600 JFK Blvd; Suite 1020; Philadelphia, PA 19103', 'Study Team (26-APR-2019)', 'Principal Investigator/Radiation Oncology', 'Radiation Oncology and Quality of Life and', 'Mark Buyyounouski, MD, MS', 'Comparative Effectiveness Research', 'Stanford University, Department of Radiation', 'Ronald Chen, MD, MPH', 'Oncology', 'University of North Carolina Chapel Hill', '875 Blake Wilbur Drive, MC5847', '101 Manning Drive', 'Stanford, CA 94305-5847', 'Chapel Hill, NC 28223', '(650) 723-6171/Fax: (650) 725-8231', '(984) 974-0400/Fax: 984) 974-8607', 'mark.buyyounouski@stanford.edu', 'ronald chen@med.unc.edu', 'Translational Science Co-chair', 'Medical Physics', 'Felix Feng, MD', 'Rajat J. Kudchadker, PhD', 'University of California, San Francisco', 'University of Texas MD Anderson Cancer', '1825 4th Street, First floor, Rm M2267', 'Ctr', 'San Francisco, CA 94143', '6767 Bertner Ave, Mitchell Bldg BSRB', '8415-353-7183/Fax: 415-353-7182', 'Houston, TX 77030', 'Felix.Feng@ucsf.edu', '(713) 563-2538/Fax: 713-563-6949', 'rkudchad@mdanderson.org', 'Urology', 'Modality Co-Chair/Health Utilities', 'Mark Mann, MD', 'Andre A. Konski, MD, MBA, MA, FACR', 'Thomas Jefferson University Hospital', 'Department of Radiation Oncology', '833 Chestnut St, Suite 703', 'University of Pennsylvania', 'Philadelphia, PA 19107', 'Chester County Hospital', 'Ph: (215) 955-1000/Fax: (215)503-2066', '701 East Marshall St, West Chester, PA', 'mark.mann@jefferson.edu', '610-431-5530', 'andre.konski@uphs.upenn.edu', 'Study Team continued on next page', 'NRG-GU003', '1', 'Version Date: April 26, 2019']['NRG ONCOLOGY', 'NRG-GU003', 'A RANDOMIZED PHASE III TRIAL OF HYPOFRACTIONATED POST-', 'PROSTATECTOMY RADIATION THERAPY (HYPORT) VERSUS CONVENTIONAL', 'POST-PROSTATECTOMY RADIATION THERAPY (COPORT)', 'Study Team continued', 'Statistician', 'Stephanie Pugh, PhD', 'NRG Oncology', '1818 Market Street, Suite 1720', 'Philadelphia, PA 19103', '215-717-0850', 'pughs@nrgoncology.org', 'The following NCTN Group Study Champions have been added to this trial:', 'ECOG-ACRIN', 'Neha Vapiwala, MD', 'University of Pennsylvania', 'Abramson Cancer Center', 'Perelman Center for Advanced Medicine/', 'Radiation Oncology', '3400 Civic Center Boulevard', 'Fourth Floor West', 'Philadelphia, PA 19104', '2145-662-7296', 'vapiwala@uphs.upenn.edu', 'SWOG', 'David Raben, MD', 'University of Colorado Cancer Center', 'Department of Radiation Oncology', '1665 Aurora Court, Suite 1032 MS F706', 'Aurora, CO 80045', '720-848-0154', 'David.raben@ucdenver.edu', 'NRG-GU003', '2', 'Version Date: April 26, 2019']\n\n###\n\n", "completion": "END"}